Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients
Colorectal cancer (CRC) ranks among the most common cancers worldwide. Surgical removal remains the best strategy for treatment of resectable tumors. An important part of caring for patients after surgery is monitoring for early detection of a possible relapse of the disease. Efforts are being made...
Main Authors: | Martin Pesta, Radek Kucera, Ondrej Topolcan, Marie Karlikova, Katerina Houfkova, Jiri Polivka, Tereza Macanova, Iva Machova, David Slouka, Vlastimil Kulda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/6/864 |
Similar Items
-
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
by: Jiri Polivka, et al.
Published: (2020-08-01) -
The possible role of tumor antigen CA 15-3, CEA and ferritin in malignant and benign disease
by: Nafija Serdarević, et al.
Published: (2012-09-01) -
CEA, CA19-9 & A-FP as tumor markers for colorectal carcinoma
by: Ansam A. AL-Bayatti, et al.
Published: (2006-04-01) -
The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels
by: Ata Naim, et al.
Published: (2014-09-01) -
The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients
by: Jiaan Kuang, et al.
Published: (2020-04-01)